Yair Lotan

The University of Texas Southwestern Medical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.842Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Long‐term outcomes of bladder‐sparing therapy vs radical cystectomy in BCG‐unresponsive non‐muscle‐invasive bladder cancer

British Journal of Urology(2024)10.1111/bju.16509

Top 24%

0.842DataRank

Top 24%27 citations

Ashish M. Kamat, Michael A. O’Donnell, Drupad Annapureddy, Jeffrey Howard, Wei Shen Tan +19 more

Papers

Driven by 22 papers — median percentile 76. Top paper: “Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin–Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial”.

Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin–Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial

The Journal of Urology(2024)10.1097/ju.0000000000004020

N/A

1.6DataRank · unranked

77 citations

Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety, Neal D. Shore, Leonard G. Gomella +35 more

The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer

Nature Communications(2024)10.1038/s41467-024-45132-2

N/A

0.988DataRank · unranked

35 citations

Karthik Reddy Kami Reddy, Yang Yuntao, Yuen San Chan, Danthasinghe Waduge Badrajee Piyarathna, Lacey E. Dobrolecki +19 more

Long‐term outcomes of bladder‐sparing therapy vs radical cystectomy in BCG‐unresponsive non‐muscle‐invasive bladder cancer

British Journal of Urology(2024)10.1111/bju.16509

Top 24%

0.842DataRank

Top 24%27 citations

Ashish M. Kamat, Michael A. O’Donnell, Drupad Annapureddy, Jeffrey Howard, Wei Shen Tan +19 more

Clinical Trial Protocol for “Replace Cysto”: Replacing Invasive Cystoscopy with Urine Testing for Non–muscle-invasive Bladder Cancer Surveillance—A Multicenter, Randomized, Phase 2 Healthcare Delivery Trial Comparing Quality of Life During Cancer Surveillance with Xpert Bladder Cancer Monitor or Bladder EpiCheck Urine Testing Versus Frequent Cystoscopy

European Urology Open Science(2024)10.1016/j.euros.2024.02.018

N/A

0.787DataRank · unranked

14 citations

Robert L. Grubb, Todd A. MacKenzie, Abdol Aziz Ould Ismail, Laura Jensen, Gregory J. Tsongalis +2 more

Mitochondrial reprogramming by activating OXPHOS via glutamine metabolism in African American patients with bladder cancer

JCI Insight(2024)10.1172/jci.insight.172336

N/A

0.523DataRank · unranked

17 citations

Danthasinghe Waduge Badrajee Piyarathna, Jun Hyoung Park, Vasanta Putluri, Chandra Sekhar Amara, Abu Hena Mostafa Kamal +21 more

Lipidomic Profiling Identifies a Novel Lipid Signature Associated with Ethnicity-Specific Disparity of Bladder Cancer

Metabolites(2022)10.3390/metabo12060544

N/A

0.452DataRank · unranked

12 citations

Danthasinghe Waduge Badrajee Piyarathna, Abu Hena Mostafa Kamal, Vasanta Putluri, Shiva Shankar Ravi, Roni J. Bollag +4 more

A Randomized Feasibility Trial Comparing Surveillance Regimens for Patients with Low and Low-Intermediate Risk Non-Muscle Invasive Bladder Cancer

Bladder Cancer(2021)10.3233/blc-201535

N/A

0DataRank · unranked

11 citations

Emily Rios, Shane Barney, Cory M. Hugen, Joel Michalek, Yair Lotan +3 more

TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells

European Urology Oncology(2022)10.1016/j.euo.2021.11.005

N/A

0DataRank · unranked

87 citations

Kai Trepka, Martin Sjöström, Emily A. Egusa, Carissa Chu, Jun Zhu +14 more

VAX014 for instillation in subjects with nonmuscle-invasive bladder cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.488

N/A

0DataRank · unranked

5 citations

Lawrence I. Karsh, Michael A. O’Donnell, Neal D. Shore, Yair Lotan, Shingo Tsuji +2 more

Mitochondrial metabolism in primary and metastatic human kidney cancers

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.06.527285

N/A

0DataRank · unranked

17 citations

Nicholas P. Lesner, Bailey Brooks, Hieu Vu, Zheng Wu, Ling Cai +27 more

Data from Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

(2023)10.1158/1078-0432.c.6530730

N/A

0DataRank · unranked

0 citations

Martin Sjöström, Emily A. Egusa, Ewan A. Gibb, Michelle L. Badura, Jun Zhu +11 more

Data from Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

(2023)10.1158/1078-0432.c.6530730.v1

N/A

0DataRank · unranked

0 citations

Martin Sjöström, Emily A. Egusa, Ewan A. Gibb, Michelle L. Badura, Jun Zhu +11 more

Mitochondrial complex I promotes kidney cancer metastasis

Nature(2024)10.1038/s41586-024-07812-3

N/A

0DataRank · unranked

117 citations

Luigi Perelli, Nicholas P. Lesner, Ling Cai, Bailey Brooks, Zheng Wu +33 more

Predicting urinary stone recurrence: a joint model analysis of repeated 24-hour urine collections from the MSTONE database

Urolithiasis(2024)10.1007/s00240-024-01653-5

N/A

0DataRank · unranked

4 citations

Brett A. Johnson, Naim M. Maalouf, Stephen Y. Nakada, Chad R. Tracy, Ryan L. Steinberg +6 more

Impact of baseline PD-L1 status in BCG naive nonmuscle invasive bladder cancer on outcomes and changes after BCG exposure

Urologic Oncology Seminars and Original Investigations(2025)10.1016/j.urolonc.2025.01.015

N/A

0DataRank · unranked

6 citations

Solomon L. Woldu, Daniel Halstuch, Yaara Ber, Karin Lifshitz, Grayden Cook +5 more

PD39-11 IMPROVED SURVIVAL AFTER CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA IN THE CONTEMPORARY IMMUNOTHERAPY ERA: A NATIONAL POPULATION-BASED ANALYSIS

The Journal of Urology(2020)10.1097/ju.0000000000000918.011

N/A

0DataRank · unranked

0 citations

Ryan Hutchinson, Rashed Ghandour, Yuval Freifeld, Dong Fang, Arthur I. Sagalowsky +6 more

Presence of an Artificial Intelligence–powered Predictive Biomarker Is Associated with a Poor Response to Intravesical Bacillus Calmette-Guerin but Not to Intravesical Sequential Gemcitabine/Docetaxel in Patients with High-grade Non–muscle-invasive Bladder Cancer

European Urology Oncology(2025)10.1016/j.euo.2025.04.006

N/A

0DataRank · unranked

6 citations

Ian M. McElree, Saum Ghodoussipour, Vivek Nimgaonkar, Viswesh Krishna, Joon Kyung Kim +15 more

Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4175

N/A

0DataRank · unranked

156 citations

Martin Sjöström, Emily A. Egusa, Ewan A. Gibb, Michelle L. Badura, Jun Zhu +11 more

Patients with Muscle-Invasive Bladder Cancer with Nonluminal Subtype Derive Greatest Benefit from Platinum Based Neoadjuvant Chemotherapy

The Journal of Urology(2021)10.1097/ju.0000000000002261

N/A

0DataRank · unranked

59 citations

Joep J. de Jong, Vinnie Y. T. Liu, Tarek A. Bismar, Stephen A. Boorjian, Huei-Chung Huang +10 more

A Multi-Institutional Phase 2 Trial of High-Dose SAbR for Prostate Cancer Using Rectal Spacer

International Journal of Radiation Oncology*Biology*Physics(2021)10.1016/j.ijrobp.2021.03.025

N/A

0DataRank · unranked

44 citations

Michael J. Zeléfsky, Raquibul Hannan, Neil Desai, Yair Lotan, Aaron Laine +9 more

SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation Trial

International Journal of Radiation Oncology*Biology*Physics(2021)10.1016/j.ijrobp.2021.10.137

N/A

0DataRank · unranked

26 citations

Samer Salamekh, Neil Desai, Aurélie Garant, Michael R. Folkert, Daniel N. Costa +15 more

MicroRNA-940 as a Potential Serum Biomarker for Prostate Cancer

Frontiers in Oncology(2021)10.3389/fonc.2021.628094

N/A

0DataRank · unranked

16 citations

Sayantan Maji, Ahmed Haddad, Yair Lotan, Rajesh Nandy, Jamboor K. Vishwanatha +2 more

Yair Lotan

Indexed papers

Top data-sharing exemplar

Papers